| AGP | α1-acid glycoprotein |
| BPH | Benign prostatic hyperplasia |
| BSA | Bovine serum albumin |
| CAT | Catalase |
| CD | Cyclodextrin |
| COX2 | Cyclooxygenase-2 |
| CS | Chitosan |
| CXCR4 | Chemokine receptor Type 4 |
| DNMT1 | DNA-methyltransferase 1 |
| DOX | Doxorubicin |
| eEF-2K | Eukaryotic elongation Factor 2 kinase |
| EMT | Epithelial-mesenchymal transition |
| EZH2 | Enhancer of zeste homolog 2 |
| GK | Gamma Knife |
| Grb2 | Growth factor receptor-binding protein 2 |
| GSH | Glutathione |
| GSH-Px | Glutathione peroxidase |
| GSK | Glycogen synthase kinase |
| HDAC | Histone deacetylase |
| HSA | Human serum albumin |
| IC50 | 50% inhibitory concentration |
| IFN | Interferon |
| IL | Interleukin |
| I3M | Indirubin-3-monoxime |
| JAK | Janus kinase |
| JNK | c-Jun N-terminal kinase pathway |
| LD50 | Median lethal dose |
| LNPs | Lipid-based nanoparticles |
| LPA | Lysophosphatidic acid |
| MA | Myristic acid |
| MAPK | Mitogen-activated protein kinase |
| MDA | malondialdehyde |
| MMP9 | Matrix metallopeptidase 9 |
| MOMP | Mitochondrial outer membrane permeability |
| mTOR | Mammalian target of rapamycin |
| NF-Kb | Nuclear factor kappa B |
| NK | Natural killer |
| NLCs | Nanostructured lipid carriers |
| PBS | Phosphate-buffered saline |
| PCL | Poly-ε-caprolactone |
| PEG | Polyethylene glycol |
| P-gp | P-glycoprotein |
| PI3K | Phosphoinositide 3-kinases |
| PLGA | Poly-lactide-co-glycolide |
| PPARγ | Peroxisome proliferator-activated receptor-γ |
| PTEN | Phosphatase and tensin homolog |
| PTK | Protein tyrosine kinase |
| PTX | Paclitaxel |
| ROS | Reactive oxygen species |
| SLNs | Solid lipid nanocarriers |
| SOD | Superoxide dismutase |
| STAT | Signal transducer and activator of transcription |
| TF | Transferrin |
| TGF-β1 | Transforming growth factor-beta 1 |
| TKI | Tyrosine kinase inhibitors |
| TME | Tumor microenvironment |
| TNBC | Triple-negative breast cancer |
| TQ | Thymoquinone |
| TRAIL | TNF-related apoptosis-inducing ligand |
| TSG | Tumor suppressor genes |
| VCAN | Versican |
| VEGFR | Vascular endothelial growth factor Receptor |